Displaying 301 - 320 of 1776
Facebook, Inc., FTC v.
The Federal Trade Commission has sued Facebook, alleging that the company is illegally maintaining its personal social networking monopoly through a years-long course of anticompetitive conduct. The complaint alleges that Facebook has engaged in a systematic strategy—including its 2012 acquisition of up-and-coming rival Instagram, its 2014 acquisition of the mobile messaging app WhatsApp, and the imposition of anticompetitive conditions on software developers—to eliminate threats to its monopoly. The Commission vote to authorize staff to file for a permanent injunction and other equitable relief in the U.S. District Court for the District of Columbia was 3-2. Commissioners Noah Joshua Phillips and Christine S. Wilson voted no.
Statement of FTC Chair Lina M. Khan on Senate Confirmation of Jonathan Kanter to Serve as Assistant Attorney General of the Department of Justice's Antitrust Division
FTC Approves Modifications to Bristol Meyers Squibb Divestiture Agreement
FTC Invites Public Comment on Draft Strategic Plan
FTC Approves Final Order Requiring Divestitures of Hundreds of Retail Gas and Diesel Fuel Stations Owned by 7-Eleven, Inc.
FTC Requires Generic Drug Marketers ANI Pharmaceuticals, Inc. and Novitium Pharma LLC to Divest Rights and Assets to Two Generic Products as Condition of Merger
FTC Announces Tentative Agenda for November 18 Open Commission Meeting
Open Commission Meeting – November 18, 2021
DaVita Inc. and Total Renal Care, Inc., In the Matter of
The Federal Trade Commission issued a proposed order imposing strict limits on future mergers by DaVita, Inc., a dialysis service provider with a history of fueling consolidation in life-saving health industries. The complaint alleged that DaVita’s proposed acquisition of the University of Utah Health’s dialysis clinics would reduce competition in vital outpatient dialysis services in the Provo, Utah market. Under the proposed order, DaVita is required to divest three Provo-area dialysis clinics to Sanderling Renal Services, Inc. and is prohibited from entering into or enforcing non-compete agreements and other employee restrictions.
FTC Requires Northeast Supermarkets Price Chopper and Tops Market Corp. to Sell 12 Stores as a Condition of Merger
Maribeth Petrizzi, Assistant Director of the Compliance Division in FTC’s Bureau of Competition, Receives 43rd Annual Roger W. Jones Award for Executive Leadership
FTC Approves Fiscal Year 2020 Hart-Scott-Rodino Premerger Notification Report
Hackensack Meridian Health, Inc. and Englewood Healthcare Foundation
The Federal Trade Commission filed an administrative complaint and authorized a suit in federal court, to block Hackensack Meridian Health, Inc.’s proposed acquisition of Englewood Healthcare Foundation. The complaint alleges that the merged healthcare system would control three of the six inpatient general acute care hospitals in Bergen County, New Jersey. The proposed acquisition would eliminate close competition between Hackensack Meridian Health and Englewood in Bergen County and leave insurers with few alternatives for inpatient general acute care services, which encompass a broad range of inpatient medical and surgical diagnostic and treatment services that require an overnight hospital stay. The administrative trial will begin 30 days after the Third Circuit Court of Appeals rules on the appeal of the Preliminary Injunction.
FTC Approves Final Order Requiring Semiconductor Supplier Broadcom to Cease Its Anticompetitive Conduct
Broadcom Incorporated, In the Matter of
The Federal Trade Commission has issued a complaint charging Broadcom with illegally monopolizing markets for semiconductor components used to deliver television and broadband internet services through exclusive dealing and related conduct. The complaint alleges that Broadcom illegally maintained its power in the three monopolized markets by entering long-term agreements with both OEMs and service providers that prevented these customers from purchasing chips from Broadcom’s competitors. The complaint also alleges that Broadcom leveraged its power in the three monopolized chip markets to extract from customers exclusivity and loyalty commitments for the supply of chips in the five related markets. Under the consent order, Broadcom must stop requiring its customers to source components from Broadcom on an exclusive or near exclusive basis.
FTC Requests Public Comment on Petition from Sartorius Stedim Biotech S.A. for Agency Approval of Its Acquisition of Chromatography Equipment Business of Novasep Process SAS
National Do Not Call Registry Data Book for Fiscal Year 2021
FTC and DOJ to Hold Virtual Public Workshop Exploring Competition in Labor Markets
Statement of the Commission on the Use of Prior Approval Provisions in Merger Orders
Displaying 301 - 320 of 1776